DK154841C - Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis - Google Patents

Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis

Info

Publication number
DK154841C
DK154841C DK475779A DK475779A DK154841C DK 154841 C DK154841 C DK 154841C DK 475779 A DK475779 A DK 475779A DK 475779 A DK475779 A DK 475779A DK 154841 C DK154841 C DK 154841C
Authority
DK
Denmark
Prior art keywords
membrane proteins
neisseria meningitidis
procedure
manufacturing membrane
optionally
Prior art date
Application number
DK475779A
Other languages
Danish (da)
English (en)
Other versions
DK154841B (da
DK475779A (da
Inventor
Torsten Bertil Helting
Gerhard Guthoehrlein
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK475779A publication Critical patent/DK475779A/da
Publication of DK154841B publication Critical patent/DK154841B/da
Application granted granted Critical
Publication of DK154841C publication Critical patent/DK154841C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK475779A 1978-11-11 1979-11-09 Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis DK154841C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2848965 1978-11-11
DE19782848965 DE2848965A1 (de) 1978-11-11 1978-11-11 Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine

Publications (3)

Publication Number Publication Date
DK475779A DK475779A (da) 1980-05-12
DK154841B DK154841B (da) 1988-12-27
DK154841C true DK154841C (da) 1989-06-05

Family

ID=6054405

Family Applications (1)

Application Number Title Priority Date Filing Date
DK475779A DK154841C (da) 1978-11-11 1979-11-09 Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis

Country Status (9)

Country Link
EP (1) EP0011243B1 (enrdf_load_stackoverflow)
JP (1) JPS5566519A (enrdf_load_stackoverflow)
AT (1) ATE857T1 (enrdf_load_stackoverflow)
AU (1) AU533386B2 (enrdf_load_stackoverflow)
CA (1) CA1142083A (enrdf_load_stackoverflow)
DE (2) DE2848965A1 (enrdf_load_stackoverflow)
DK (1) DK154841C (enrdf_load_stackoverflow)
ES (1) ES485715A1 (enrdf_load_stackoverflow)
IL (1) IL58673A (enrdf_load_stackoverflow)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317811A (en) 1980-09-11 1982-03-02 Merck & Co., Inc. Herpes simplex type 1 subunit vaccine
EP0127681B1 (en) * 1982-12-02 1993-03-03 The Rockefeller University Iga binding protein
US7118757B1 (en) 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
BR9910749A (pt) 1998-05-29 2001-02-13 Chiron Corp Composições e vacinas imunogênicas combinadas para meningites b e c e método de induzir uma resposta imune por administração da mesma
BR0010721A (pt) 1999-05-19 2002-06-11 Chiron Spa Composições de neisserias combinadas
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
EP2275129A3 (en) 2000-01-17 2013-11-06 Novartis Vaccines and Diagnostics S.r.l. Outer membrane vesicle (OMV) vaccine comprising N. meningitidis serogroup B outer membrane proteins
GB0103171D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
AU2003260357B2 (en) 2002-08-02 2009-10-29 Glaxosmithkline Biologicals S.A. Vaccine compositions comprising L2 and/or L3 immunotype lipooligosaccharides from lgtB- Neisseria minigitidis
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
CU23313A1 (es) 2002-11-27 2008-09-25 Inst Finlay Ct De Investigacia Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
CA2550927A1 (en) * 2003-12-23 2005-07-14 Glaxosmithkline Biologicals S.A. A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection
GB0419627D0 (en) 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
JP5275982B2 (ja) 2006-06-12 2013-08-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム ワクチン
AU2008313424B2 (en) 2007-10-19 2014-05-22 Novartis Ag Meningococcal vaccine formulations
RU2475496C2 (ru) 2008-02-21 2013-02-20 Новартис Аг МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHBP
GB0822634D0 (en) 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
EP2367568A2 (en) 2008-12-17 2011-09-28 Novartis AG Meningococcal vaccines including hemoglobin receptor
EP2440245B1 (en) 2009-06-10 2017-12-06 GlaxoSmithKline Biologicals SA Benzonaphthyridine-containing vaccines
AU2010288239B2 (en) 2009-08-27 2014-01-16 Novartis Ag Adjuvant comprising aluminium, oligonucleotide and polycation
EP3017828A1 (en) 2009-08-27 2016-05-11 GlaxoSmithKline Biologicals SA Hybrid polypeptides including meningococcal fhbp sequences
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
GB0917003D0 (en) 2009-09-28 2009-11-11 Novartis Vaccines Inst For Global Health Srl Purification of bacterial vesicles
CA2776004A1 (en) 2009-09-30 2011-04-07 Novartis Ag Expression of meningococcal fhbp polypeptides
BR112012010531A2 (pt) 2009-10-27 2019-09-24 Novartis Ag "polipeptídeos de modificação meningocócica fhbp"
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
AU2010339921B2 (en) 2009-12-15 2016-08-11 Glaxosmithkline Biologicals S.A. Homogeneous suspension of immunopotentiating compounds and uses thereof
WO2011110634A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Vaccine composition
MX2012010609A (es) 2010-03-18 2012-10-03 Novartis Ag Vacunas adyuvadas para meningococos serogrupo b.
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
AU2011300418B2 (en) 2010-09-10 2016-05-12 Glaxosmithkline Biologicals Sa Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom
GB201015132D0 (en) 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
EP2707009A1 (en) 2011-05-12 2014-03-19 Novartis AG Antipyretics to enhance tolerability of vesicle-based vaccines
JP5957541B2 (ja) 2012-02-02 2016-07-27 ノバルティス アーゲー 髄膜炎菌における増加したタンパク質発現のためのプロモータ
WO2013132040A2 (en) 2012-03-08 2013-09-12 Novartis Ag In vitro potency assay for protein-based meningococcal vaccines
NZ630133A (en) 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
MX2015002717A (es) 2012-09-06 2015-05-15 Novartis Ag Vacunas combinadas con meningococo del serogrupo b y toxoides de difteria/tetanos/tosferina.
WO2014044728A1 (en) 2012-09-18 2014-03-27 Novartis Ag Outer membrane vesicles
SI3110442T1 (sl) 2014-02-28 2021-01-29 Glaxosmithkline Biologicals S.A. Modificirani meningokokni fHbp polipeptidi
WO2018042017A2 (en) 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae
AU2018330322A1 (en) 2017-09-08 2020-03-19 Evelo Biosciences, Inc. Bacterial extracellular vesicles
EP3607967A1 (en) 2018-08-09 2020-02-12 GlaxoSmithKline Biologicals S.A. Modified meningococcal fhbp polypeptides
MX2021005303A (es) 2018-11-06 2021-07-07 Glaxosmithkline Biologicals Sa Composiciones inmunogenicas.
EP3799884A1 (en) 2019-10-01 2021-04-07 GlaxoSmithKline Biologicals S.A. Immunogenic compositions
GB202115072D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay
GB202211033D0 (en) 2022-07-28 2022-09-14 Glaxosmithkline Biologicals Sa Purification process

Also Published As

Publication number Publication date
IL58673A (en) 1983-02-23
DK154841B (da) 1988-12-27
EP0011243A1 (de) 1980-05-28
AU5268279A (en) 1980-05-15
DE2848965A1 (de) 1980-05-22
ATE857T1 (de) 1982-04-15
DK475779A (da) 1980-05-12
IL58673A0 (en) 1980-02-29
JPS5566519A (en) 1980-05-20
DE2962526D1 (en) 1982-05-27
JPS6350332B2 (enrdf_load_stackoverflow) 1988-10-07
CA1142083A (en) 1983-03-01
AU533386B2 (en) 1983-11-24
EP0011243B1 (de) 1982-04-14
ES485715A1 (es) 1980-05-16

Similar Documents

Publication Publication Date Title
DK154841C (da) Fremgangsmaade til fremstilling af membranproteiner ud fra neisseria meningitidis
DE69423383D1 (de) Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
ATE195420T1 (de) Methode zur herstellung von eicosapentansäuren
DE69116305D1 (de) Verfahren zur Herstellung von Trehalulose und Isomaltulose
DK32684A (da) Fremgangsmaade til fremstilling af 26,26,26,27,27,27-hexafluor-1alfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
ATE123947T1 (de) Echinacea-extrakte, verfahren zur herstellung und zubereitungen, die sie enthalten.
EP0009206A3 (en) Fluor-containing 1,4-dihydropyridines, process for their preparation and their application in pharmaceuticals
ES2127726T3 (es) Un metodo para la preparacion de hemoglobina piridoxilada.
MX165343B (es) Tratamiento de membranas permeables
AT384032B (de) Verfahren zur herstellung von polydispersen nativen pseudomonas-flagella(h)-antigenen (fag)
OA08446A (fr) Procédé et installation pour améliorer du café grillé.
EP0607593A3 (de) Verfahren zur Gewinnnung von Zellkulturen mit erhöhtem Gehalt an körpereigenen Zytokinen.
ATE161051T1 (de) Verfahren zur herstellung aktivierter sialinsäuren
ES8104789A1 (es) Procedimiento para la separacion de leucina, isoleucina y valina
ATE86666T1 (de) Verfahren zur herstellung von l-sorbose und vorrichtung zur kultivierung von mikroorganismen.
FR2517967B1 (enrdf_load_stackoverflow)
ATE116989T1 (de) Verfahren zur reinigung von hemin, neues heminderivat und verfahren zur herstellung.
FR2620726B1 (fr) Procede de preparation d'un extrait de jasmin et extrait obtenu
NO984206L (no) Fremgangsmaate for fremstilling av N-beskyttende D-prolinderivater
ATE118008T1 (de) Verfahren zur herstellung von aminomethanphosphonsäure und aminomethyl- phosphinsäuren.
SU1564190A1 (ru) Способ получени препарата фотосинтетических реакционных центров, содержащих фотоактивные цитохромы
JPS57201600A (en) Treatment of organic sludge
GB1556005A (en) Process for ozone treatment of water
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
DK632187A (da) Ny forbedret fremgangsmaade til fremstilling af penicillansyrederivater

Legal Events

Date Code Title Description
PBP Patent lapsed